The Centers for Medicare & Medicaid Services has announced a plan to cover a new class of Alzheimer’s disease drugs if they receive full approval from the US Food and Drug Administration – and with some limitations
Alzheimer’s drugs that slow the progression of cognitive decline will be covered by Medicare as long as they’ve received traditional approval from the FDA and the clinical team gathers data for a registry of how the drugs work in the real world, CMS said. “If the FDA grants traditional approval CMS is prepared to ensure anyone with Medicare Part B who meets the criteria is covered,” CMS Administrator Chiquita Brooks-LaSure said in a statement.
“Additionally, patients can’t access treatments through any and every provider if they are required to participate in a registry, which means seniors seeking to access these treatments will potentially have to travel to a new provider to be treated.” The FDA has granted accelerated approval to the Alzheimer’s medications lecanemab, marketed as Leqembi, and Aduhelm.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Medicare Plans to Cover Alzheimer’s DrugsMedicare plans to widen coverage of Alzheimer’s drugs that could win full approval as soon as this summer
Leer más »
Medicare to expand coverage for a new class of costly Alzheimer’s drugsMedicare officials announced plans to broadly cover a new class of Alzheimer’s drugs following an intense lobbying campaign by patient advocates and drugmakers pressing for access to the first medications shown to slow cognitive decline from the disease.
Leer más »
Medicare unveils plan for coverage of new Alzheimer’s drugsPatient registry could be a barrier to coverage of new treatments, critics say.
Leer más »
Medicare plans to pay for Alzheimer's drugs that win full FDA approvalMedicare says it will pay for new Alzheimer’s drugs that are granted full approval from the FDA, although it will require physicians to collect data on how well the drugs perform in the real world.
Leer más »
Chains Overcharging Medicare for Drugs Can Be Sued for Fraud, Supreme Court RulesThe Supreme Court said lawsuits could proceed alleging that Safeway and Supervalu defrauded the government by claiming reimbursements at list price for drugs that they typically sold at discounted rates
Leer más »
Medicare details plan to cover Alzheimer's treatmentsPatients will have to participate in registries that collect real-world data on how the drug works as a condition of coverage.
Leer más »